OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer
Wei Huang, Yuanyuan Li, Cheng Zhang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 23, pp. 13949-13960
Open Access | Times Cited: 103
Wei Huang, Yuanyuan Li, Cheng Zhang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 23, pp. 13949-13960
Open Access | Times Cited: 103
Showing 1-25 of 103 citing articles:
Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 146
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 146
A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
Riya Thapa, Gaurav Gupta, Asif Ahmad Bhat, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127375-127375
Closed Access | Times Cited: 86
Riya Thapa, Gaurav Gupta, Asif Ahmad Bhat, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127375-127375
Closed Access | Times Cited: 86
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
Tianyu Zhu, Lian‐Lian Hong, Zhi‐Qiang Ling
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 45
Tianyu Zhu, Lian‐Lian Hong, Zhi‐Qiang Ling
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 45
DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery
Wei Lan, Haibo Liao, Qingfeng Chen, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 3
Open Access | Times Cited: 17
Wei Lan, Haibo Liao, Qingfeng Chen, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 3
Open Access | Times Cited: 17
IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
Xin Xu, Jiangtao Cui, Hong Wang, et al.
Materials Today Bio (2022) Vol. 17, pp. 100503-100503
Open Access | Times Cited: 58
Xin Xu, Jiangtao Cui, Hong Wang, et al.
Materials Today Bio (2022) Vol. 17, pp. 100503-100503
Open Access | Times Cited: 58
The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer
Chao‐Yue Sun, Cao Di, Bin-Bin Du, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2744-2758
Open Access | Times Cited: 52
Chao‐Yue Sun, Cao Di, Bin-Bin Du, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2744-2758
Open Access | Times Cited: 52
Targeting IGF2BP3 in Cancer
Xin Liu, Jiayu Chen, Wenliang Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9423-9423
Open Access | Times Cited: 25
Xin Liu, Jiayu Chen, Wenliang Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9423-9423
Open Access | Times Cited: 25
CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability
Feifei Yang, Qiang Ma, Bo Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Feifei Yang, Qiang Ma, Bo Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment
Meiqi Duan, Haiyang Liu, Shasha Xu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 890-920
Open Access | Times Cited: 23
Meiqi Duan, Haiyang Liu, Shasha Xu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 890-920
Open Access | Times Cited: 23
IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation
Like Yang, Bingrui Yan, Lingmei Qu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 5, pp. 1382-1400
Open Access | Times Cited: 22
Like Yang, Bingrui Yan, Lingmei Qu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 5, pp. 1382-1400
Open Access | Times Cited: 22
IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development
Lei Lv, Qinqin Wei, Jianxiao Zhang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 12
Lei Lv, Qinqin Wei, Jianxiao Zhang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 12
N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128–3p/MAPK1 axis
Jiahe Yi, Xueyou Ma, Yufan Ying, et al.
Cancer Letters (2024) Vol. 585, pp. 216613-216613
Open Access | Times Cited: 11
Jiahe Yi, Xueyou Ma, Yufan Ying, et al.
Cancer Letters (2024) Vol. 585, pp. 216613-216613
Open Access | Times Cited: 11
The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis
Xin Zhang, Suwen Chen, Guoliang Yin, et al.
Journal of Cardiovascular Pharmacology and Therapeutics (2024) Vol. 29
Open Access | Times Cited: 8
Xin Zhang, Suwen Chen, Guoliang Yin, et al.
Journal of Cardiovascular Pharmacology and Therapeutics (2024) Vol. 29
Open Access | Times Cited: 8
RNA-binding proteins: Underestimated contributors in tumorigenesis
Yubo Zhao, Cristina Mir, Yoelsis García-Mayea, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 431-444
Closed Access | Times Cited: 31
Yubo Zhao, Cristina Mir, Yoelsis García-Mayea, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 431-444
Closed Access | Times Cited: 31
IL4I1 enhances PD-L1 expression through JAK/STAT signaling pathway in lung adenocarcinoma
Jiefei Zhu, Yan Li, Xu Lv
Immunogenetics (2022) Vol. 75, Iss. 1, pp. 17-25
Closed Access | Times Cited: 28
Jiefei Zhu, Yan Li, Xu Lv
Immunogenetics (2022) Vol. 75, Iss. 1, pp. 17-25
Closed Access | Times Cited: 28
IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner
Lijie Chen, Hui-Ye Liu, Zhiyuan Xiao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 20
Lijie Chen, Hui-Ye Liu, Zhiyuan Xiao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 20
IGF2BP3-stabilized CAMK1 regulates the mitochondrial dynamics of renal tubule to alleviate diabetic nephropathy
Yuan Du, Hao Li, Wenni Dai, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167022-167022
Closed Access | Times Cited: 6
Yuan Du, Hao Li, Wenni Dai, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167022-167022
Closed Access | Times Cited: 6
m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer
Zhihui Zhang, Chaoqi Zhang, Yuejun Luo, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 38
Zhihui Zhang, Chaoqi Zhang, Yuejun Luo, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 38
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 27
CPEB2 m6A methylation regulates blood–tumor barrier permeability by regulating splicing factor SRSF5 stability
Mengyang Zhang, Chunqing Yang, Xuelei Ruan, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 23
Mengyang Zhang, Chunqing Yang, Xuelei Ruan, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 23
Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer
Fahim Anwar Rizwi, Md. Abubakar, Eswara Rao Puppala, et al.
Journal of Environmental Pathology Toxicology and Oncology (2023) Vol. 42, Iss. 4, pp. 15-29
Closed Access | Times Cited: 13
Fahim Anwar Rizwi, Md. Abubakar, Eswara Rao Puppala, et al.
Journal of Environmental Pathology Toxicology and Oncology (2023) Vol. 42, Iss. 4, pp. 15-29
Closed Access | Times Cited: 13
IGF2BP3 as a Prognostic Biomarker and Regulator of Metastasis in Merkel Cell Carcinoma
Yajie Yang, Jiwei Gao, Hao Shi, et al.
JID Innovations (2025) Vol. 5, Iss. 3, pp. 100355-100355
Open Access
Yajie Yang, Jiwei Gao, Hao Shi, et al.
JID Innovations (2025) Vol. 5, Iss. 3, pp. 100355-100355
Open Access
IFNγ/JAK1/STAT1 signaling represses FOXA1 and drives a basal transcriptional state in muscle-invasive bladder cancer
Sarah H. Lawrence, Hironobu Yamashita, Lauren Shuman, et al.
American Journal Of Pathology (2025)
Open Access
Sarah H. Lawrence, Hironobu Yamashita, Lauren Shuman, et al.
American Journal Of Pathology (2025)
Open Access
Downregulated STAT3 and STAT5B are prognostic biomarkers for colorectal cancer and are associated with immune infiltration
Qier Li, Jingzhi Wang, Qingqing Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Qier Li, Jingzhi Wang, Qingqing Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
